Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Examining the factor structure of the multiple sclerosis impact scale.
Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study.
Diagnosing neuromyelitis optica.
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples.
[Therapeutic options for autoimmune encephalomyelitis].
Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
Demyelinating encephalopathy in adult onset Still's disease: Case report and review of the literatures.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores.
Late-onset clozapine-induced agranulocytosis in a patient with comorbid multiple sclerosis.
[Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: A systematic review].
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.
Autoantibodies in pre-clinical autoimmune disease.
Multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
Autonomic dysfunction in multiple sclerosis.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
Orienting network dysfunction in progressive multiple sclerosis.
Neuropsychological rehabilitation has beneficial effects on perceived cognitive deficits in multiple sclerosis during nine-month follow-up.
Natalizumab and the development of extensive brain lesions in neuromyelitis optica.
Management of psoriasis vulgaris and multiple sclerosis with fumaric acid.
Multiple sclerosis is associated with psoriasis. A case-control study.
Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2(+) glial cells.
A comparison between plasmapheresis and intravenous immunoglobulin in children with Guillain-Barré syndrome in Upper Egypt.
Antibodies to aquaporin-1 are not present in neuromyelitis optica.
Pages
« first
‹ previous
…
429
430
431
432
433
434
435
436
437
…
next ›
last »